What is the current NAV of HDFC Pharma and Healthcare Fund - Growth Option?

The current NAV (Net Asset Value) of HDFC Pharma and Healthcare Fund - Growth Option is ₹20.56. NAV is updated every business day after market close by AMFI.

What is the 1-year return of HDFC Pharma and Healthcare Fund - Growth Option?

HDFC Pharma and Healthcare Fund - Growth Option has delivered a 1-year CAGR return of 21.27% as of the latest data.

What is the expense ratio of HDFC Pharma and Healthcare Fund - Growth Option?

Expense ratio data for HDFC Pharma and Healthcare Fund - Growth Option is not yet available.

Who manages HDFC Pharma and Healthcare Fund - Growth Option?

HDFC Pharma and Healthcare Fund - Growth Option is managed by HDFC Mutual Fund.

What is the risk level of HDFC Pharma and Healthcare Fund - Growth Option?

HDFC Pharma and Healthcare Fund - Growth Option is classified as a Very High risk fund. It is suitable for aggressive investors with a long-term horizon of 5+ years.

What is the minimum SIP amount for HDFC Pharma and Healthcare Fund - Growth Option?

You can start a SIP in HDFC Pharma and Healthcare Fund - Growth Option with as little as ₹500 per month through most mutual fund platforms. The minimum lump sum investment is typically ₹1,000.

info

Data shown is for informational purposes only and does not constitute investment advice. TopFund is not SEBI-registered. Consult a SEBI-registered advisor before investing.

HDFC Pharma and Healthcare Fund - Growth Option

HDFC Mutual Fund · Equity · Sectoral/ Thematic

₹20.56

-0.05 (-0.22%) trending_down

AUM: —

NAV updated 12 days ago

compare_arrows Compare

Plan

—

Option

Growth

Risk

Very High

Expense Ratio

—

Exit Load

—

Fund Manager

—

Inception

—

Benchmark

—

Sharpe Ratio

0.89

Std Dev (1Y)

13.44%

Historical Returns (CAGR)

Annualized trailing returns computed from NAV history — past performance only, not a guarantee of future results.

+5.93%

+18.05%

+19.37%

+21.27%

—

10y

—

since inception

+30.17%

rate_review TopFund's Take on HDFC Pharma and Healthcare Fund - Growth Option

HDFC Pharma and Healthcare Fund - Growth Option is a Sectoral/ Thematic fund from HDFC Mutual Fund.

Cost: Expense ratio data for this fund isn't available yet.

Risk-adjusted performance: Over the trailing 1-year period, the fund shows a moderate Sharpe ratio of 0.89 — decent risk-adjusted performance, without being exceptional. Separately, annualised volatility of 13.44% is fairly typical for actively managed equity funds.

Who should invest: This fund is best suited to investors whose goals and risk appetite align with a Equity fund. Given the Very High risk rating, this fund is not suited to short-term goals or investors who may need to exit within 2-3 years.

This is an automated, data-driven analysis based on the fund's own metrics and its category peers — not personalized investment advice. Consult a SEBI-registered advisor before investing.